These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 36362028)

  • 1. Anti-Metastatic Effect of Pyruvate Dehydrogenase Kinase 4 Inhibition in Bladder Cancer via the ERK, SRC, and JNK Pathways.
    Lee EH; Chung JW; Sung E; Yoon BH; Jeon M; Park S; Chun SY; Lee JN; Kim BS; Kim HT; Kim TH; Choi SH; Yoo ES; Kwon TG; Kang HW; Kim WJ; Yun SJ; Lee S; Ha YS
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36362028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Pyruvate Dehydrogenase Kinase-4 (PDK4) in Bladder Cancer and Chemoresistance.
    Woolbright BL; Choudhary D; Mikhalyuk A; Trammel C; Shanmugam S; Abbott E; Pilbeam CC; Taylor JA
    Mol Cancer Ther; 2018 Sep; 17(9):2004-2012. PubMed ID: 29907593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cryptotanshinone, a novel PDK 4 inhibitor, suppresses bladder cancer cell invasiveness via the mTOR/β‑catenin/N‑cadherin axis.
    Kim CJ; Terado T; Tambe Y; Mukaisho KI; Kageyama S; Kawauchi A; Inoue H
    Int J Oncol; 2021 Jul; 59(1):. PubMed ID: 33982789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming Growth Factor β Mediates Drug Resistance by Regulating the Expression of Pyruvate Dehydrogenase Kinase 4 in Colorectal Cancer.
    Zhang Y; Zhang Y; Geng L; Yi H; Huo W; Talmon G; Kim YC; Wang SM; Wang J
    J Biol Chem; 2016 Aug; 291(33):17405-16. PubMed ID: 27330076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor activity of potent pyruvate dehydrogenase kinase 4 inhibitors from plants in pancreatic cancer.
    Tambe Y; Terado T; Kim CJ; Mukaisho KI; Yoshida S; Sugihara H; Tanaka H; Chida J; Kido H; Yamaji K; Yamamoto T; Nakano H; Omura S; Inoue H
    Mol Carcinog; 2019 Oct; 58(10):1726-1737. PubMed ID: 31106493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic inactivation of pyruvate dehydrogenase kinases improves hepatic insulin resistance induced diabetes.
    Tao R; Xiong X; Harris RA; White MF; Dong XC
    PLoS One; 2013; 8(8):e71997. PubMed ID: 23940800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Pyruvate Dehydrogenase Kinase 4 Attenuates Myocardial and Mitochondrial Injury in Sepsis-Induced Cardiomyopathy.
    Chen T; Ye L; Zhu J; Tan B; Yi Q; Sun Y; Xie Q; Xiang H; Wang R; Tian J; Xu H
    J Infect Dis; 2024 Apr; 229(4):1178-1188. PubMed ID: 37624974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FoxO1 regulates myocardial glucose oxidation rates via transcriptional control of pyruvate dehydrogenase kinase 4 expression.
    Gopal K; Saleme B; Al Batran R; Aburasayn H; Eshreif A; Ho KL; Ma WK; Almutairi M; Eaton F; Gandhi M; Park EA; Sutendra G; Ussher JR
    Am J Physiol Heart Circ Physiol; 2017 Sep; 313(3):H479-H490. PubMed ID: 28687587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammation increases pyruvate dehydrogenase kinase 4 (PDK4) expression via the Jun N-Terminal Kinase (JNK) pathway in C2C12 cells.
    Park H; Jeoung NH
    Biochem Biophys Res Commun; 2016 Jan; 469(4):1049-54. PubMed ID: 26740179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diverging regulation of pyruvate dehydrogenase kinase isoform gene expression in cultured human muscle cells.
    Abbot EL; McCormack JG; Reynet C; Hassall DG; Buchan KW; Yeaman SJ
    FEBS J; 2005 Jun; 272(12):3004-14. PubMed ID: 15955060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abrogating PDK4 activates autophagy-dependent ferroptosis in breast cancer via ASK1/JNK pathway.
    Shi W; Wang J; Chen J; Jin X; Wang Y; Yang L
    J Cancer Res Clin Oncol; 2024 Apr; 150(4):218. PubMed ID: 38678126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyruvate dehydrogenase kinase 4: regulation by thiazolidinediones and implication in glyceroneogenesis in adipose tissue.
    Cadoudal T; Distel E; Durant S; Fouque F; Blouin JM; Collinet M; Bortoli S; Forest C; Benelli C
    Diabetes; 2008 Sep; 57(9):2272-9. PubMed ID: 18519799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyruvate Dehydrogenase Kinase 4 Deficiency Increases Tumorigenesis in a Murine Model of Bladder Cancer.
    Woolbright BL; Rajendran G; Abbott E; Martin A; Didde R; Dennis K; Harris RA; Taylor JA
    Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FOXO1-mediated upregulation of pyruvate dehydrogenase kinase-4 (PDK4) decreases glucose oxidation and impairs right ventricular function in pulmonary hypertension: therapeutic benefits of dichloroacetate.
    Piao L; Sidhu VK; Fang YH; Ryan JJ; Parikh KS; Hong Z; Toth PT; Morrow E; Kutty S; Lopaschuk GD; Archer SL
    J Mol Med (Berl); 2013 Mar; 91(3):333-46. PubMed ID: 23247844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coenzyme A-mediated degradation of pyruvate dehydrogenase kinase 4 promotes cardiac metabolic flexibility after high-fat feeding in mice.
    Schafer C; Young ZT; Makarewich CA; Elnwasany A; Kinter C; Kinter M; Szweda LI
    J Biol Chem; 2018 May; 293(18):6915-6924. PubMed ID: 29540486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of Pyruvate Dehydrogenase Kinase 4 in the Heart through Degradation by the Lon Protease in Response to Mitochondrial Substrate Availability.
    Crewe C; Schafer C; Lee I; Kinter M; Szweda LI
    J Biol Chem; 2017 Jan; 292(1):305-312. PubMed ID: 27856638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the pyruvate dehydrogenase complex/pyruvate dehydrogenase kinase (PDC/PDK) axis to discover potent PDK inhibitors through structure-based virtual screening and pharmacological evaluation.
    Gan L; Yang Y; Liang Z; Zhang M; He Y; Zhang SL
    Eur J Med Chem; 2024 Jan; 264():116008. PubMed ID: 38056298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyruvate dehydrogenase kinase 4 mediates lipogenesis and contributes to the pathogenesis of nonalcoholic steatohepatitis.
    Zhang M; Zhao Y; Li Z; Wang C
    Biochem Biophys Res Commun; 2018 Jan; 495(1):582-586. PubMed ID: 29128353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of pyruvate dehydrogenase kinase 4 (PDK4) by thyroid hormone: role of the peroxisome proliferator-activated receptor gamma coactivator (PGC-1 alpha).
    Attia RR; Connnaughton S; Boone LR; Wang F; Elam MB; Ness GC; Cook GA; Park EA
    J Biol Chem; 2010 Jan; 285(4):2375-85. PubMed ID: 19948729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted upregulation of pyruvate dehydrogenase kinase (PDK)-4 in slow-twitch skeletal muscle underlies the stable modification of the regulatory characteristics of PDK induced by high-fat feeding.
    Holness MJ; Kraus A; Harris RA; Sugden MC
    Diabetes; 2000 May; 49(5):775-81. PubMed ID: 10905486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.